Cocrystal Pharma (8CC.F) Q3 2025 Earnings

14AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-0.54
-0.42
-0.29
-0.17

Details

Expected EPS
-0.1974228
Actual EPS
-0.17167200000000002
Surprise EPS
0.03
Surprise Percent
+13.04%

Description

Cocrystal Pharma (8CC.F) has reported earnings of -0.17167200000000002 per share for Q3 2025.

0 Comments

Share your thoughts